Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Free Articles

These articles are provided free to all readers.  Other free articles are available in Week in Review, In My Opinion, and Education Center.  To have access to all of our articles, click here...

Week in Review: Pharmaron, a Beijing CRO, Stages $434 Million Hong Kong IPO

Week in Review: Fosun Pharma Acquires Brain Cancer Immunotherapy in $148 Million Deal

China's Glut of PD-1/PD-L1 Candidates -- How Can They All Find a Market?

AstraZeneca Plans $1 Billion Fund for China Biopharma Startups

Week in Review: Taimei Raises $212 Million for AI Life Science Support Software

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China